Day: April 28, 2021
Marked return to growth
Q1 turnover: €593.8 millionin € million
Q1 2021
Q1 2020
Change
France
250.5
271.9
-7.9%International
343.3
304.6
+12.7%
Total
593.8
576.5
+3.0%The SYNERGIE Group has begun 2021 with a marked return to growth, posting consolidated turnover on a like for like basis of €593.8 million (+3% compared with 2020).
This performance was achieved thanks to the strategy implemented in France and in all the countries in which the Group operates, enabling it to conquer new markets in high-growth sectors (logistics, call centres, healthcare, agri-food, environment, digital and activities related to the transformation of cities).
During the quarter, activity was again boosted by International, which strengthened its positions in both Northern Europe (+5%) and Southern Europe (+21.2%), where Italy played...
Une analyse intermédiaire de l’étude de Phase III d’extension en ouvert en cours montre un benefice durable du traitement avec PXT3003 chez les patients atteints de la maladie de Charcot-Marie-Tooth de type 1A (CMT1A)
Written by Customer Service on . Posted in Public Companies.
Une analyse intermédiaire de l’étude de Phase III d’extension en ouvert en cours montre un benefice durable du traitement avec PXT3003 chez les patients atteints de la maladie de Charcot-Marie-Tooth de type 1A (CMT1A)
Les nouveaux résultats suggèrent un bon profil de sécurité et une efficacité durable de PXT3003, évaluée sur l’échelle ONLS (Overall Neuropathy Limitation Scale), après une durée totale de 4 ans et demi d‘essai clinique
Une conférence téléphonique et un webinar se tiendront demain jeudi 29 avril à 14h00 CET (8h00 ET)
PARIS, France, le 28 avril 2021 à 18h00 (CET) – Pharnext SA (FR0011191287 – ALPHA) (« La Société »), société biopharmaceutique à un stade clinique avancé, pionnière d’une nouvelle approche de développement de combinaisons de médicaments innovantes basée sur les Big Data génomiques et l’intelligence...
Communiqué: Orange prices its 500 million euro, undated, 8-year non-call, deeply subordinated fixed to reset rate notes
Written by Customer Service on . Posted in Public Companies.
Press releaseParis, 28 April 2021
NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA
Orange prices its 500 million euro, undated, 8-year non-call, deeply subordinated fixed to reset rate notes
Orange S.A. (the Company) successfully priced its issuance of €500,000,000 undated 8 year non-call deeply subordinated fixed to reset rate notes with a fixed coupon of 1.375% until the first call date (the Notes).
The Notes are scheduled to be admitted to trading on Euronext Paris. It is also expected that rating agencies assign the New Notes a rating of Baa3/BBB- (Moody’s/ S&P) and an equity content of 50%.
The Company also launched a tender offer (the Tender Offer) to repurchase its:€1,000,000,000 Undated 7 Year Non-Call Deeply Subordinated Fixed to Reset Rate Notes with first call date on 1 October 2021 (of which €118,374,000 is...
Interim Analysis from the Ongoing Open-Label Phase III Extension Study Shows Sustained Benefits of PXT3003 for Patients with Charcot-Marie-Tooth Disease Type 1A (‘CMT1A’)
Written by Customer Service on . Posted in Public Companies.
Interim Analysis from the Ongoing Open-Label Phase III Extension Study Shows Sustained Benefits of PXT3003 for Patients with Charcot-Marie-Tooth Disease Type 1A (‘CMT1A’)
New results suggest good safety profile and sustained efficacy of PXT3003 as measured with the Overall Neuropathy Limitation Scale (‘ONLS’), after 4.5 years of total trial time.
A live conference call and webcast will be held tomorrow, Thursday April 29that 2:00 p.m. CET (8:00 a.m. ET)
PARIS, France, April 28, 2021, 6:00 p.m. CET – Pharnext SA (FR0011191287 – ALPHA) (the ‘Company’), an advanced late-stage clinical biopharmaceutical company pioneering new approaches to developing innovative drug combinations based on big genomics data and artificial intelligence using its PLEOTHERAPY™ platform, today announces new results from an interim analysis of an ongoing open-label...
Interim Analysis from the Ongoing Open-Label Phase III Extension Study Shows Sustained Benefits of PXT3003 for Patients with Charcot-Marie-Tooth Disease Type 1A (‘CMT1A’)
Written by Customer Service on . Posted in Public Companies.
Interim Analysis from the Ongoing Open-Label Phase III Extension Study Shows Sustained Benefits of PXT3003 for Patients with Charcot-Marie-Tooth Disease Type 1A (‘CMT1A’)
New results suggest good safety profile and sustained efficacy of PXT3003 as measured with the Overall Neuropathy Limitation Scale (‘ONLS’), after 4.5 years of total trial time.
A live conference call and webcast will be held tomorrow, Thursday April 29that 2:00 p.m. CET (8:00 a.m. ET)
PARIS, France, April 28, 2021, 6:00 p.m. CET – Pharnext SA (FR0011191287 – ALPHA) (the ‘Company’), an advanced late-stage clinical biopharmaceutical company pioneering new approaches to developing innovative drug combinations based on big genomics data and artificial intelligence using its PLEOTHERAPY™ platform, today announces new results from an interim analysis of an ongoing open-label...
Festi hf.: Afkoma á 1. ársfjórðungi 2021
Written by Customer Service on . Posted in Public Companies.
Helstu niðurstöðurFramlegð af vöru- og þjónustusölu nam 5.144 millj. kr. samanborið við 4.304 millj. kr. á 1F 2020, sem samsvarar 19,5% hækkun milli ára.
EBITDA nam 1.505 millj. kr. samanborið við 1.021 millj. kr. á 1F 2020, sem jafngildir 47,5% hækkun.
Framlegð af vörusölu var 24,6% á 1F 2021 en framlegðin var 22,9% á sama fjórðungi árið áður.
Kostnaður vegna COVID-19 var 37 millj. kr. á 1F 2021 en var 48 millj. kr. á sama fjórðungi árið áður.
Eigið fé í lok 1F 2021 var 29.227 m.kr. og eiginfjárhlutfall 34,8% samanborið við 35,7% í lok árs 2020.
Nettó vaxtaberandi skuldir án leiguskuldbindinga var 30.276 millj. kr. í lok 1F 2021 samanborið við 29.986 millj. kr. í lok 2020.
EBITDA spá félagsins fyrir árið 2021 er hækkuð um 400 millj. kr. og er nú 7.900 – 8.300 millj. kr. Eggert Þór Kristófersson, forstjóri Festi:
Niðurstaða...
UPM-Kymmene Corporation: Managers’ Transactions (Brunow)
Written by Customer Service on . Posted in Public Companies.
UPM-Kymmene Corporation Stock Exchange Release (Managers’ Transactions) 28 April 2021 at 18:00 EEST
UPM-Kymmene Corporation: Managers’ Transactions (Brunow)
On 30 March 2021, the Annual General Meeting of UPM-Kymmene Corporation resolved that the annual base fee of the company’s Board of Directors is paid in the company shares and cash so that approximately 40% is payable in the company shares to be purchased on the Board members’ behalf, and the rest in cash. In accordance with this resolution, a total of 1,710 shares have been purchased to Berndt Brunow as follows:
Person subject to the notification requirementName: Brunow, BerndtPosition: Deputy Chair of the BoardIssuer: UPM-Kymmene CorporationLEI: 213800EC6PW5VU4J9U64
Notification type: INITIAL NOTIFICATION____________________________________________
Transaction...
UPM-Kymmene Corporation: Managers’ Transactions (Gustafsson)
Written by Customer Service on . Posted in Public Companies.
UPM-Kymmene Corporation Stock Exchange Release (Managers’ Transactions) 28 April 2021 at 18:00 EEST
UPM-Kymmene Corporation: Managers’ Transactions (Gustafsson)
On 30 March 2021, the Annual General Meeting of UPM-Kymmene Corporation resolved that the annual base fee of the company’s Board of Directors is paid in the company shares and cash so that approximately 40% is payable in the company shares to be purchased on the Board members’ behalf, and the rest in cash. In accordance with this resolution, a total of 1,405 shares have been purchased to Jari Gustafsson as follows:
Person subject to the notification requirementName: Gustafsson, JariPosition: Member of the BoardIssuer: UPM-Kymmene CorporationLEI: 213800EC6PW5VU4J9U64
Notification type: INITIAL NOTIFICATION____________________________________________
Transaction...
DTE Strengthens Pledge to Net Zero Goal by Collaborating with Automakers to Optimize EV Charging
Written by Customer Service on . Posted in Public Companies.
DETROIT, April 28, 2021 (GLOBE NEWSWIRE) — DTE Energy, Michigan’s largest energy company, is collaborating with Electric Vehicle (EV) manufacturers to optimize EV charging through the new DTE Smart Charge program. This program aims to help the company balance energy demand on the grid while moving closer to its environmental goal of achieving net zero carbon emissions by 2050.
DTE Smart Charge is a Demand Response (DR) program that will monitor and study EV charging and peak usage events. The program is looking for 1,000 volunteer EV owners who have the potential to earn up to $100 in gift cards depending on their participation level. This initiative is open to all Michigan residents who have a qualifying EV and receive residential electric service from DTE Energy.
DTE is among one of a few energy companies in the U.S. running...
ServisFirst Bank Announces New Hire to Tampa Bay Banking Team
Written by Customer Service on . Posted in Public Companies.
Jason Costello Named Pinellas County Executive
TAMPA, Fla., April 28, 2021 (GLOBE NEWSWIRE) — ServisFirst Bank, a subsidiary of ServisFirst Bancshares (NASDAQ:SFBS), recently announced the addition of Jason Costello to ServisFirst Bank Tampa as Pinellas County Executive. In this role, Costello will assist commercial clients with their banking needs in the Tampa Bay area as he oversees the growth of ServisFirst Bank to Pinellas county.
“We are very pleased to have Jason join our commercial team,” stated Gwynn Davey, ServisFirst Bank Tampa Bay Region President. “His broad experience and well-known reputation in the community will help us to expand our presence in Pinellas County.”
Jason Costello, Pinellas County ExecutiveWith over sixteen years of successful banking experience, Jason Costello joins ServisFirst Bank as an experienced...